Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Linsitinib | 0.31623 | uM | 10 | 1250.00 | 353.09 | 1123.67 | 1166.25 | 0.9639 | 0.9579 |
| MCF7 | Linsitinib | 1 | uM | 10 | 1250.00 | 353.09 | 816.67 | 1166.25 | 0.7016 | 0.6282 |
| MCF7 | Linsitinib | 3.1623 | uM | 10 | 1250.00 | 353.09 | 669.00 | 1166.25 | 0.5716 | 0.4419 |
| MCF7 | Linsitinib | 10 | uM | 10 | 1250.00 | 353.09 | 636.67 | 1166.25 | 0.5477 | 0.4100 |
| MCF7 | Linsitinib | 19.9526 | uM | 10 | 1250.00 | 353.09 | 559.67 | 1166.25 | 0.4811 | 0.3072 |
| MCF7 | Palbociclib | 0.0033113 | uM | 10 | 1250.00 | 353.09 | 2509.00 | 2368.75 | 1.0578 | 1.0383 |
| MCF7 | Palbociclib | 0.01 | uM | 10 | 1250.00 | 353.09 | 2234.00 | 2368.75 | 0.9606 | 0.9760 |
| MCF7 | Palbociclib | 0.031623 | uM | 10 | 1250.00 | 353.09 | 2243.33 | 2368.75 | 0.9793 | 1.0017 |
| MCF7 | Palbociclib | 0.1 | uM | 10 | 1250.00 | 353.09 | 2263.33 | 2368.75 | 0.9466 | 0.9479 |
| MCF7 | Palbociclib | 0.31623 | uM | 10 | 1250.00 | 353.09 | 1609.33 | 2368.75 | 0.7156 | 0.7631 |
| MCF7 | Palbociclib | 1 | uM | 10 | 1250.00 | 353.09 | 995.00 | 2368.75 | 0.4192 | 0.4092 |
| MCF7 | Palbociclib | 3.1623 | uM | 10 | 1250.00 | 353.09 | 977.33 | 2368.75 | 0.4316 | 0.4361 |
| MCF7 | Palbociclib | 10 | uM | 10 | 1250.00 | 353.09 | 831.00 | 2368.75 | 0.3793 | 0.3641 |
| MCF7 | Palbociclib | 19.9526 | uM | 10 | 1250.00 | 353.09 | 918.00 | 2368.75 | 0.4077 | 0.4040 |
| MCF7 | 17-AAG | 0.0016596 | uM | 10 | 2500.00 | 703.32 | 2710.67 | 2608.58 | 1.0392 | 1.0401 |
| MCF7 | 17-AAG | 0.0033113 | uM | 10 | 2500.00 | 703.32 | 2820.00 | 2608.58 | 1.0814 | 1.0834 |
| MCF7 | 17-AAG | 0.01 | uM | 10 | 2500.00 | 703.32 | 2378.67 | 2608.58 | 0.9120 | 0.9001 |
| MCF7 | 17-AAG | 0.031623 | uM | 10 | 2500.00 | 703.32 | 1345.33 | 2608.58 | 0.5154 | 0.4052 |
| MCF7 | 17-AAG | 0.1 | uM | 10 | 2500.00 | 703.32 | 946.33 | 2608.58 | 0.3627 | 0.1693 |
| MCF7 | 17-AAG | 0.31623 | uM | 10 | 2500.00 | 703.32 | 746.00 | 2608.58 | 0.2860 | 0.0304 |
| MCF7 | 17-AAG | 1 | uM | 10 | 2500.00 | 703.32 | 761.00 | 2608.58 | 0.2917 | 0.0422 |
| MCF7 | 17-AAG | 3.1623 | uM | 10 | 2500.00 | 703.32 | 707.00 | 2608.58 | 0.2710 | 0.0023 |
| MCF7 | 17-AAG | 10 | uM | 10 | 2500.00 | 703.32 | 694.33 | 2608.58 | 0.2663 | -0.0070 |
| MCF7 | Erlotinib | 0.0033113 | uM | 10 | 2500.00 | 703.32 | 2700.67 | 2608.58 | 1.0354 | 1.0370 |
| MCF7 | Erlotinib | 0.01 | uM | 10 | 2500.00 | 703.32 | 2766.33 | 2608.58 | 1.0609 | 1.0620 |